Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01325207
Title Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Northwestern University
Indications

Her2-receptor positive breast cancer

Therapies

Trastuzumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco (UCSF) San Francisco California 94143-1710 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Tufts Medical Center Boston Massachusetts 02111 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University New York New York 10032 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Rhode Island Hospital Providence Rhode Island 02903 United States Details
Texas Oncology-Austin Austin Texas 78705 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field